Drug Reference
Bempedoic Acid / Ezetimibe
Combinations of various lipid modifying agents
Fact box
- Therapeutic class
- Combinations of various lipid modifying agents
Brand names
Nexlizet
Available as
180 MG · Oral Tablet
Multi-ingredient product
Bempedoic AcidEzetimibe
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.